X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5032) 5032
Publication (234) 234
Book Review (32) 32
Book Chapter (5) 5
Conference Proceeding (3) 3
Magazine Article (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4564) 4564
antineoplastic combined chemotherapy protocols - therapeutic use (3246) 3246
female (2953) 2953
male (2784) 2784
oncology (2723) 2723
ifosfamide - administration & dosage (2631) 2631
adult (2488) 2488
middle aged (2300) 2300
ifosfamide (1985) 1985
chemotherapy (1692) 1692
aged (1650) 1650
cisplatin - administration & dosage (1185) 1185
etoposide - administration & dosage (1181) 1181
index medicus (1178) 1178
treatment outcome (1164) 1164
adolescent (1056) 1056
ifosfamide - therapeutic use (1032) 1032
antineoplastic combined chemotherapy protocols - adverse effects (1005) 1005
cancer (992) 992
doxorubicin - administration & dosage (928) 928
combined modality therapy (909) 909
ifosfamide - adverse effects (879) 879
cisplatin (811) 811
lung neoplasms - drug therapy (710) 710
child (697) 697
prognosis (641) 641
etoposide (601) 601
survival rate (597) 597
disease-free survival (562) 562
carboplatin - administration & dosage (551) 551
drug administration schedule (547) 547
vincristine - administration & dosage (526) 526
survival analysis (524) 524
neoplasm staging (523) 523
sarcoma - drug therapy (518) 518
cyclophosphamide - administration & dosage (505) 505
retrospective studies (490) 490
doxorubicin (479) 479
therapy (476) 476
pharmacology & pharmacy (469) 469
child, preschool (465) 465
hematology (462) 462
cyclophosphamide (460) 460
antineoplastic combined chemotherapy protocols - administration & dosage (455) 455
salvage therapy (424) 424
remission induction (420) 420
sarcoma (415) 415
antineoplastic agents - therapeutic use (414) 414
chemotherapy, adjuvant (395) 395
follow-up studies (394) 394
carboplatin (385) 385
animals (376) 376
survival (367) 367
carcinoma, non-small-cell lung - drug therapy (366) 366
methotrexate - administration & dosage (345) 345
tumors (344) 344
young adult (342) 342
paclitaxel - administration & dosage (335) 335
bone neoplasms - drug therapy (333) 333
paclitaxel (333) 333
dose-response relationship, drug (332) 332
care and treatment (330) 330
trial (328) 328
phase-ii trial (327) 327
phase-ii (325) 325
mesna - administration & dosage (323) 323
antineoplastic agents, alkylating - therapeutic use (315) 315
children (312) 312
pediatrics (312) 312
surgery (308) 308
radiotherapy (294) 294
prospective studies (281) 281
medicine & public health (280) 280
neoplasm recurrence, local - drug therapy (279) 279
carcinoma (269) 269
cisplatin - adverse effects (269) 269
mesna (268) 268
cisplatin - therapeutic use (261) 261
neoplasms - drug therapy (260) 260
infant (257) 257
time factors (257) 257
soft tissue neoplasms - drug therapy (255) 255
doxorubicin - therapeutic use (252) 252
etoposide - therapeutic use (252) 252
aged, 80 and over (251) 251
etoposide - adverse effects (250) 250
combination chemotherapy (241) 241
antineoplastic agents, alkylating - administration & dosage (237) 237
testicular neoplasms - drug therapy (234) 234
vinblastine - administration & dosage (234) 234
deoxycytidine - analogs & derivatives (232) 232
obstetrics & gynecology (231) 231
osteosarcoma - drug therapy (230) 230
bleomycin - administration & dosage (227) 227
gemcitabine (227) 227
neoplasm metastasis (227) 227
high-dose chemotherapy (222) 222
toxicity (221) 221
infusions, intravenous (220) 220
risk factors (214) 214
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4586) 4586
Japanese (159) 159
German (112) 112
French (79) 79
Chinese (37) 37
Polish (18) 18
Spanish (18) 18
Italian (11) 11
Russian (5) 5
Bulgarian (2) 2
Czech (2) 2
Hebrew (2) 2
Hungarian (2) 2
Lithuanian (2) 2
Turkish (2) 2
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BACKGROUND Double‐hit lymphomas (DHLs) are collectively defined as B‐cell non‐Hodgkin lymphomas harboring rearrangements of MYC as well as B‐cell lymphoma 2... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 2011, Volume 22, Issue 5, pp. 1221 - 1227
Journal Article
Haematologica, ISSN 0390-6078, 2017, Volume 102, Issue 2, pp. 356 - 363
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 488 - 497
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2017, Volume 83, Issue 10, pp. 2148 - 2162
Aims Aprepitant and fosaprepitant, commonly used for the prevention of chemotherapy‐induced nausea and vomiting, alter cytochrome P450 activity. This... 
aprepitant | drug–drug interactions | fosaprepitant | METHYLENE-BLUE | CHEMOTHERAPY-INDUCED NAUSEA | SITE ADVERSE EVENTS | CYTOCHROME-P450 3A4 | IFOSFAMIDE | drug-drug interactions | CANCER-PATIENTS | CONCISE GUIDE | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | RECEPTOR ANTAGONIST APREPITANT | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Nausea - chemically induced | Humans | Antineoplastic Agents - therapeutic use | Drug Interactions | Cytochrome P-450 CYP2C9 Inducers - pharmacology | Antiemetics - therapeutic use | Antineoplastic Agents - pharmacology | Vomiting - prevention & control | Morpholines - therapeutic use | Quetiapine Fumarate - pharmacology | Aprepitant | Oxycodone - therapeutic use | Oxycodone - pharmacology | Injection Site Reaction - etiology | Serotonin Uptake Inhibitors - therapeutic use | Morpholines - pharmacology | Quetiapine Fumarate - therapeutic use | Nausea - prevention & control | Vomiting - chemically induced | Ethanol - pharmacology | Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology | Cytochrome P-450 CYP2C9 Inducers - therapeutic use | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Cytochrome P-450 CYP3A Inhibitors - therapeutic use | Antiemetics - pharmacology | Complications and side effects | Anthracyclines | Chemotherapy | Corticosteroids | Gastrointestinal agents | Drug interactions | Nausea | Cancer | Index Medicus | Systematic Review and Meta–Analysis
Journal Article
Journal Article
Journal Article